KRYS - Krystal Biotech, Inc.
NEXT EARNINGS:
May 5, 2026
EPS Est: $1.51
|
Rev Est: $112.1M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$311.00
DETAILS
HIGH:
$371.00
LOW:
$224.00
MEDIAN:
$323.00
CONSENSUS:
$311.00
UPSIDE:
19.18%
Market Cap:
7.63B
Volume:
201,157
Avg Volume:
338,182
52 Week Range:
122.8-298.303
Sector:
Healthcare
Industry:
Biotechnology
Beta:
0.51
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
275
IPO Date:
2017-09-20
EPS (TTM):
7.08
P/E Ratio:
36.86
Revenue (TTM):
389.13M
Total Assets:
1.33B
Total Debt:
9.34M
Cash & Equiv:
496.30M
Rev Growth (5Y):
156.2%
EPS Growth (5Y):
680.0%
FCF Growth (5Y):
N/A
ROCE:
13.1%
Debt/Equity:
0.01
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-17 | $1.70 | $1.62 | +4.9% | $107.1M | $105.3M | +1.7% |
| 2025-11-03 | $2.66 | $1.12 | +137.5% | $97.8M | $105.3M | -7.1% |
| 2025-08-04 | $1.29 | $1.08 | +19.4% | $96.0M | $95.4M | +0.7% |
| 2025-05-06 | $1.20 | $1.38 | -13.0% | $88.2M | $106.0M | -16.8% |
| 2025-02-19 | $1.52 | $1.29 | +17.8% | $91.1M | $91.4M | -0.2% |
| 2024-11-04 | $0.91 | $0.90 | +1.1% | $83.8M | $91.3M | -8.2% |
| 2024-08-05 | $0.86 | $0.50 | +72.0% | $70.3M | $65.3M | +7.6% |
| 2024-05-06 | $0.03 | $0.15 | -80.0% | $45.2M | $47.4M | -4.6% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 389.13M | 290.51M | 50.70M | 0 | 0 | 0 | 0 | 1.03M | 0 | 0 |
| Net Income | 204.83M | 89.16M | 10.93M | (139.97M) | (69.57M) | (32.17M) | (19.09M) | (10.89M) | (7.92M) | (1.15M) |
| EPS | 7.08 | 3.12 | 0.40 | -5.49 | -3.13 | -1.71 | -1.20 | -0.97 | -1.48 | -0.27 |
| Total Assets | 1.33B | 1.06B | 818.36M | 558.45M | 626.29M | 310.84M | 209.02M | 116.12M | 50.11M | 2.18M |
| Total Debt | 9.34M | 7.26M | 8.09M | 8.93M | 8.02M | 11.55M | 3.26M | 0 | 0 | 1.84M |
| Cash & Equivalents | 496.30M | 344.87M | 358.33M | 161.90M | 341.25M | 268.27M | 187.51M | 103.67M | 49.59M | 1.92M |
| Operating Cash Flow | 200.87M | 123.42M | (88.80M) | (100.57M) | (47.94M) | (26.08M) | (18.71M) | (9.45M) | (3.89M) | (1.31M) |
| Free Cash Flow | 188.91M | 119.18M | (100.60M) | (153.55M) | (116.27M) | (40.93M) | (25.11M) | (11.68M) | (4.10M) | (1.33M) |
| FCF per Share | 6.53 | 4.17 | -3.70 | -6.02 | -5.24 | -2.18 | -1.58 | -1.04 | -0.76 | -0.31 |
| Book Value | 1.22B | 946.38M | 778.64M | 522.23M | 593.58M | 292.08M | 202.91M | 113.23M | 49.47M | 289,000 |
| Cash & ST Investments | 827.79M | 597.52M | 532.18M | 379.17M | 438.10M | 271.26M | 193.69M | 111.76M | 49.59M | 1.92M |
| Return on Equity | 0.17 | 0.09 | 0.01 | -0.27 | -0.12 | -0.11 | -0.09 | -0.10 | -0.16 | -3.98 |